22nd Century Group, Inc.

22nd Century Expands the Pinnacle Pure Portfolio To 6 SKU’s With Addition of 100’s and Menthol Varieties

VenHub Global Inc.

VenHub and Follett Higher Education Form Strategic Partnership to Expand 24/7 Autonomous Retail Across College and University Campuses

Partnership Establishes a Scalable Model to Deploy VenHub Smart Stores to a Broad Network of Higher Education Campuses

Duchesnay inc.

Initiation of a Phase III Clinical Study of BON-001 for Nausea and Vomiting of Pregnancy in Japan

TransCode Therapeutics, Inc.

TransCode Therapeutics Presents Phase 1a Clinical Data for TTX-MC138 at ESMO Congress 2026

Ferrari N.V.

FERRARI N.V.: PERIODIC REPORT ON THE BUYBACK PROGRAM

PowerBank Corporation

PowerBank Strengthens Balance Sheet and Solar Portfolio with 14% Reduction in Project Debt with Completion of CA$25.4M Refinancing

Quantum Cyber

Quantum Cyber Invited to Present Quantum Antenna Technology at QuantumCT Quantum Sensing Convening

Company outlined magnetic navigation as an initial commercial development objective and discussed potential quantum communications and energy harvesting applications at Connecticut research and industry event

CAE Inc.

CAE to sell Flightscape to SITA

Davion Healthcare Plc

Davion Healthcare Announces US$25 Million Acquisition of Humaskan Medical Technology IP

Acquisition adds battery-free smart wound dressing and two-minute multi-marker screening test to Davion’s growing healthcare portfolio

Zimmer Biomet Holdings, Inc.

Arthritis Foundation and Founding Sponsor Zimmer Biomet Announce New Community Celebrating Life After Joint Replacement and Inspiring Others to Act on Severe Joint Pain

Maxus Mining Inc.

Maxus Mining Engages Understood Mineral Resources to Advance Resource-Focused Work at Quarry Project

Technical program builds on historical exploration and resource-focused work at the historic Bullseye Zone

TuHURA Biosciences, Inc.

TuHURA Biosciences Provides First Look at Data from its Open-Label Study of IFx-2.0 as an Adjunctive Therapy to Keytruda® in First Line Treatment of Patients with Deep Seated Metastatic Merkel Cell Carcinoma

Immuneering Corporation

Immuneering Presents Design and Methodology of Ongoing Phase 3 MAPKeeper 301 Trial at ESMO Congress 2026

Xilio Therapeutics, Inc.

Xilio Therapeutics Announces First Patient Dosed in Phase 1/2 Clinical Trial of XTX501 in Patients with Metastatic NSCLC

Biohaven Ltd.

Biohaven Oral Presentation at ASN Kidney Week 2026 Spotlights BHV-1420, a Novel TRAP Degrader Designed to Selectively Remove the Autoantibodies that Drive Membranous Nephropathy

Ocean Power Technologies, Inc.

Ocean Power Technologies and Stratum Holdings Sign Letter of Intent for Proposed Strategic Collaboration to Demonstrate Offshore Renewable-Powered Data Center Assets

Companies to combine OPT’s PowerBuoy® platforms and patent portfolio with Stratum’s GPU infrastructure to advance edge AI inference powered by wave, wind, and solar energy

NAPCO Security Technologies, Inc.

NAPCO Security Technologies to Announce Fiscal First Quarter 2027 Results Monday, November 2, 2026

BrainsWay

BrainsWay Expands U.S. Insurance Coverage for Deep TMS™ Treatment of OCD to Over 118 Million Lives